more assumptions stood on their ear: pCR after neoadjuvant treatment for her2+ breast

[Debbie L.]

Thanks for the clarification, Lani. Can you post a link to the full study, and to the editorial you mention? I'm curious to see the numbers, and the discussion.

Rich, I agree -- to discuss concurrent chemo and endocrine tx (not just neoadjuvantly, but that is where we might get some quick answers), we should probably start a new thread. There is really very little evidence about this, especially in the metastatic setting. And I can think of some excellent arguments for why it should work just fine.

Debbie Laxague